Low-dose recombinant activated factor VII (rF-VIIa) for excess hemorrhage after cardiac operation

Annals of Thoracic Surgery

Volumn 99, Issue 5, 2015, Pages 1870-

  Safani, Michael ^a   Drachenberg, Milton R ^a   Ferro, Emanuel T ^a   Hill, Stanley E ^a   Thomas, Gregory S ^a   Bethencourt, Daniel M ^a  

^a Memorial Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A;

CORONARY ARTERY BYPASS GRAFT; DRUG DOSE COMPARISON; DRUG MEGADOSE; HEART SURGERY; HUMAN; IMMOBILITY; JEHOVAH'S WITNESS; KIDNEY FAILURE; LETTER; LOW DRUG DOSE; LUNG EMBOLISM; MORTALITY; NEUROLOGIC DISEASE; OBESITY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; FEMALE; MALE;

CARDIAC SURGICAL PROCEDURES; FACTOR VIIA; FEMALE; HUMANS; MALE;

EID: 84929377162     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2014.12.018     Document Type: Letter

References (3)

1. A. Alfirevic, A. Duncan, and J. You Recombinant factor VII is associated with worse survival in complex cardiac surgical patients Ann Thorac Surg 98 2014 618 624
2. E. Simpson, Y. Lin, and S. Stanworth Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia Cochrane Database Syst Rev 3 2012 CD005011
3. I. Hers, and A. Mumford Understanding the therapeutic action of recombinant factor VIIa in platelet disorders Platelets 19 2008 571 581